Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer

Diagnostic Cytopathology

Volumn 40, Issue 5, 2012, Pages 394-398

  Trimboli, P ^a   Rossi, F ^a   Baldelli, R ^b   Laurenti, O ^a   Nigri, G ^c   Ventura, C ^a   Appetecchia, M ^b   Attanasio, D ^d   Romanelli, F ^e   Guidobaldi, L ^a   Guarino, M ^a   Crescenzi, A ^a   Valabrega, S ^c  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Azienda Sanitaria Locale   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

calcitonin; fine needle aspiration; medullary thyroid carcinoma; washout measurement

Indexed keywords

CALCITONIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DEVICE; MALE; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID METASTASIS; THYROID NODULE;

ADULT; AGED; BIOPSY, FINE-NEEDLE; CALCITONIN; CELL NUCLEUS; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; NEOPLASM GRADING; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860229872     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21731     Document Type: Article

References (17)

1. Ball DW, Baylin SB, de Bustros AC,. Medullary thyroid carcinoma. In:, Braverman LE, Utiger RD, editors. Thyroid, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. 930 p.
2. Bugalho MJM, Santos JR, Sobrinho L,. Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 2005; 91: 56-60. (Pubitemid 40967381)
3. Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004; 89: 163-168. (Pubitemid 38183876)
4. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA,. Calcitonin measurement in the evaluation of thyroid nodules in the United States: A cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008; 93: 2173-2180. (Pubitemid 351831532)
5. Costante G, Meringolo D, Durante C, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455.
6. Rodding AH, Levine SN, Fowler MR,. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000; 10: 919-922.
7. Hamy A, Pessaux P, Mirallie E, et al. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. Eur J Surg Oncol 2005; 31: 774-777. (Pubitemid 41194656)
8. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 2010; 33: 1-50.
9. Giovanella L, Suriano S,. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules. Head Neck 2010; 33: 95-97.
10. Kim JM, Chung KW, Kim SW, et al. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies. Head Neck 2010; 32: 68-75.
11. Karanikas G, Moameni A, Poetzi C, et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 2004; 85: 919-922.
12. Chambon G, Alovisetti C, Idoux-Louche C, et al. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: Results from 2733 consecutive patients. J Clin Endocrinol Metabol 2011; 96: 75-81.
13. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612.
14. Boi F, Maurelli I, Pinna G, et al. Calcitonin measurement in washout fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 2115-2118. (Pubitemid 46997108)
15. Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M,. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine needle aspiration biopsy specimens. Thyroid 2007; 17: 635-638. (Pubitemid 47311552)
16. Massaro F, Dolcino M, Degrandi R, et al. Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone. J Endocrinol Invest 2009; 32: 308-312.
17. Abraham D, Gault PM, Hunt J, Bentz J,. Calcitonin estimation in neck lymph node fine-needle aspirate fluid prevents misinterpretation of cytology in patients with metastatic medullary thyroid cancer. Thyroid 2009; 19: 1015-1016.